Logo of canmedLink to Publisher's site
PMC full text:

TABLE 3

Tumour size change and Ki‐67 level change compared with categorical variables.

Parameter (n = 44)Decreased tumour size relative to the median p Value (chi‐square)Decreased Ki‐67 level relative to the median p Value (chi‐square)
Good (n) (>4.5 mm)Bad (n) (<=4.5 mm)Good (n) (>9)Bad (n) (<= 9)
Menopausal status
Premenopausal460.71350.42
Postmenopausal18161610
Intrinsic subtype
Luminal A1010113150.0001
Luminal B1012615
Nuclear Grade
G1770.98560.70
G21011117
G31111
RCB class
I220.54220.79
II19181819
III2121
PD‐L1 before NET
PD‐L1 (−)1920117140.60
PD‐L1 (+)22214
PD‐L1 after NET
PD‐L1 (−)1616114101
PD‐L1 (+)5654
PD‐1 before NET
PD‐1 (+)18150.2812130.17
PD‐1 (−)2661
PD‐1 after NET
PD‐1 (+)15120.281360.18
PD‐1 (−)51058
CTLA‐4 before NET
CTLA‐4 (−)17140.311580.34
CTLA‐4 (+)3735
CTLA‐4 after NET
CTLA‐4 (−)13140.8112101
CTLA‐4 (+)7564
TIM‐3 before NET
TIM‐3 (−)860.74751
TIM‐3 (+)1315119
TIM‐3 after NET
TIM‐3 (−)981740.93
TIM‐3 (+)1112119
LAG‐3 before NET
LAG‐3 (−)1270.27580.23
LAG‐3 (+)913126
LAG‐3 after NET
LAG‐3 (−)761260.09
LAG‐3 (+)1415168

Abbreviations: RCB, Residual Cancer Burden; NET, neoadjuvant endocrine therapy.

Note: Bold values denote statistical significance at the p < 0.05 level.